Abstract
The avascularity of cardiac valves is abrogated in several valvular heart diseases (VHDs). This study investigated the molecular mechanisms underlying valvular avascularity and its correlation with VHD. Chondromodulin-I, an antiangiogenic factor isolated from cartilage, is abundantly expressed in cardiac valves. Gene targeting of chondromodulin-I resulted in enhanced Vegf-A expression, angiogenesis, lipid deposition and calcification in the cardiac valves of aged mice. Echocardiography showed aortic valve thickening, calcification and turbulent flow, indicative of early changes in aortic stenosis. Conditioned medium obtained from cultured valvular interstitial cells strongly inhibited tube formation and mobilization of endothelial cells and induced their apoptosis; these effects were partially inhibited by chondromodulin-I small interfering RNA. In human VHD, including cases associated with infective endocarditis, rheumatic heart disease and atherosclerosis, VEGF-A expression, neovascularization and calcification were observed in areas of chondromodulin-I downregulation. These findings provide evidence that chondromodulin-I has a pivotal role in maintaining valvular normal function by preventing angiogenesis that may lead to VHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hammon, J.W., Jr ., O'Sullivan, M.J., Oury, J. & Fosburg, R.G. Allograft cardiac valves. A view through the scanning electron microscope. J. Thorac. Cardiovasc. Surg. 68, 352–360 (1974).
Soini, Y., Salo, T. & Satta, J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum. Pathol. 34, 756–763 (2003).
Yamauchi, R. et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol. 24, 282–287 (2004).
Filip, D.A., Radu, A. & Simionescu, M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ. Res. 59, 310–320 (1986).
Lester, W., Rosenthal, A., Granton, B. & Gotlieb, A.I. Porcine mitral valve interstitial cells in culture. Lab. Invest. 59, 710–719 (1988).
Gotlieb, A.I., Rosenthal, A. & Kazemian, P. Fibroblast growth factor 2 regulation of mitral valve interstitial cell repair in vitro. J. Thorac. Cardiovasc. Surg. 124, 591–597 (2002).
Akiyama, H. et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. USA 101, 6502–6507 (2004).
Ranger, A.M. et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186–190 (1998).
Rajamannan, N.M. et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107, 2181–2184 (2003).
Chan-Thomas, P.S., Thompson, R.P., Robert, B., Yacoub, M.H. & Barton, P.J. Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick. Dev. Dyn. 197, 203–216 (1993).
Sugi, Y., Yamamura, H., Okagawa, H. & Markwald, R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 269, 505–518 (2004).
Camenisch, T.D. et al. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 248, 170–181 (2002).
Ikeda, T. et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 50, 3561–3573 (2004).
Hiraki, Y. [Molecular cloning of a novel cartilage-specific functional matrix, chondromodulin-I, and its role in endochondral bone formation]. Seikagaku 63, 1449–1454 (1991).
Funaki, H. et al. Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye. Invest. Ophthalmol. Vis. Sci. 42, 1193–1200 (2001).
Azizan, A., Holaday, N. & Neame, P.J. Post-translational processing of bovine chondromodulin-I. J. Biol. Chem. 276, 23632–23638 (2001).
Hiraki, Y. et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem. 272, 32419–32426 (1997).
Inoue, H., Kondo, J., Koike, T., Shukunami, C. & Hiraki, Y. Identification of an autocrine chondrocyte colony-stimulating factor: chondromodulin-I stimulates the colony formation of growth plate chondrocytes in agarose culture. Biochem. Biophys. Res. Commun. 241, 395–400 (1997).
Shukunami, C. & Hiraki, Y. Expression of cartilage-specific functional matrix chondromodulin-I mRNA in rabbit growth plate chondrocytes and its responsiveness to growth stimuli in vitro. Biochem. Biophys. Res. Commun. 249, 885–890 (1998).
Hiraki, Y., Kono, T., Sato, M., Shukunami, C. & Kondo, J. Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I. FEBS Lett. 415, 321–324 (1997).
Zacks, S. et al. Characterization of Cobblestone mitral valve interstitial cells. Arch. Pathol. Lab. Med. 115, 774–779 (1991).
Oshima, Y. et al. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest. Ophthalmol. Vis. Sci. 44, 1814–1823 (2003).
Hiraki, Y. et al. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells. Eur. J. Biochem. 260, 869–878 (1999).
Shukunami, C., Iyama, K., Inoue, H. & Hiraki, Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int. J. Dev. Biol. 43, 39–49 (1999).
Shukunami, C., Yamamoto, S., Tanabe, T. & Hiraki, Y. Generation of multiple transcripts from the chicken chondromodulin-I gene and their expression during embryonic development. FEBS Lett. 456, 165–170 (1999).
Dietz, U.H., Ziegelmeier, G., Bittner, K., Bruckner, P. & Balling, R. Spatio-temporal distribution of chondromodulin-I mRNA in the chicken embryo: expression during cartilage development and formation of the heart and eye. Dev. Dyn. 216, 233–243 (1999).
Sachdev, S.W. et al. Sequence analysis of zebrafish chondromodulin-1 and expression profile in the notochord and chondrogenic regions during cartilage morphogenesis. Mech. Dev. 105, 157–162 (2001).
Chalajour, F. et al. Angiogenic activation of valvular endothelial cells in aortic valve stenosis. Exp. Cell Res. 298, 455–464 (2004).
Takeda, S., Bonnamy, J.P., Owen, M.J., Ducy, P. & Karsenty, G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467–481 (2001).
Dawson, D.W. et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285, 245–248 (1999).
Shworak, N.W. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways? Curr. Opin. Cardiol. 19, 140–146 (2004).
Mohler, E.R., III . et al. Bone formation and inflammation in cardiac valves. Circulation 103, 1522–1528 (2001).
Mazzone, A. et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J. Am. Coll. Cardiol. 43, 1670–1676 (2004).
O'Brien, K.D., McDonald, T.O., Chait, A., Allen, M.D. & Alpers, C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93, 672–682 (1996).
Moulton, K.S. et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA 100, 4736–4741 (2003).
Otto, C.M., Kuusisto, J., Reichenbach, D.D., Gown, A.M. & O'Brien, K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90, 844–853 (1994).
O'Brien, K.D. et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 92, 2163–2168 (1995).
Agmon, Y. et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J. Am. Coll. Cardiol. 38, 827–834 (2001).
O'Brien, K.D. et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106, 2224–2230 (2002).
Pohle, K. et al. Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography. Mayo Clin. Proc. 79, 1242–1246 (2004).
Rabkin, E. et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104, 2525–2532 (2001).
Fondard, O. et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur. Heart J. 26, 1333–1341 (2005).
Enomoto, H. et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am. J. Pathol. 162, 171–181 (2003).
Fujimoto, N. & Iwata, K. Use of EIA to measure MMPs and TIMPs. Methods Mol. Biol. 151, 347–358 (2001).
Tanaka, K. et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 46, 134–141 (2005).
Nakamichi, Y. et al. Chondromodulin I is a bone remodeling factor. Mol. Cell. Biol. 23, 636–644 (2003).
Kyuwa, S., Xiao, Y., Toyoda, Y. & Sato, E. Characterization of embryonic stem-like cell lines derived from embryoid bodies. Exp. Anim. 46, 11–16 (1997).
Litwin, S.E., Katz, S.E., Morgan, J.P. & Douglas, P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89, 345–354 (1994).
Acknowledgements
We thank Y. Nishizaki and S. Kondo for technical support. This study was supported in part by research grants from the Ministry of Education, Science and Culture, Japan, and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation.
Author information
Authors and Affiliations
Contributions
This study was designed by K.F.; experiments were performed by M.Y., S.Y., K.M., K.K. and N.K.; the Chm1 knockout mouse and antibody to Chm-I were made by C.S. and Y.H.; surgical specimens were collected by M.M., H.S. and R.Y.; the MMP experiment was performed by T.S. and Y.O.; specimens from Apoe knockout mice were distributed by M.S.; S.O. contributed to the writing of the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Temporal and spatial expression of Chm1 in rodent and human heart (PDF 2002 kb)
Supplementary Fig. 2
Immunofluorescent staining for Chm-I in middle- and late-stage embryonic mouse heart. (PDF 287 kb)
Supplementary Fig. 3
Antiangiogenic effect of recombinant human CHM-I on HCAECs in vitro. (PDF 224 kb)
Supplementary Fig. 4
MTT assay for VICs. (PDF 982 kb)
Supplementary Fig. 5
Cbfa1-positive cells were detected in vascular areas in VHD. (PDF 189 kb)
Supplementary Fig. 6
Immunohistochemistry of the cardiac valves for MMP-1, -2, -3, -9 and -13 in humans with various VHDs. (PDF 450 kb)
Supplementary Fig. 7
Activated myofibroblasts were detected in vascular areas in VHD. (PDF 279 kb)
Supplementary Fig. 8
The conceptual framework of the role of Chm-I in cardiac valves. (PDF 1790 kb)
Rights and permissions
About this article
Cite this article
Yoshioka, M., Yuasa, S., Matsumura, K. et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med 12, 1151–1159 (2006). https://doi.org/10.1038/nm1476
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1476
This article is cited by
-
Epigenome-wide association study in peripheral white blood cells involving insulin resistance
Scientific Reports (2019)
-
Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease
Cellular and Molecular Life Sciences (2019)
-
Scleraxis is a transcriptional activator that regulates the expression of Tenomodulin, a marker of mature tenocytes and ligamentocytes
Scientific Reports (2018)
-
Calcific Aortic Valve Disease: a Developmental Biology Perspective
Current Cardiology Reports (2018)
-
Proteomic Alterations Associated with Biomechanical Dysfunction are Early Processes in the Emilin1 Deficient Mouse Model of Aortic Valve Disease
Annals of Biomedical Engineering (2017)